Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fuki Ikeda

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
The Journal of Biological Chemistry|April 3, 2003
p38 MAPK is involved in activin A- and hepatocyte growth factor-mediated expression of pro-endocrine gene neurogenin 3 in AR42J-B13 cellsTakeshi Ogihara, Hirotaka Watada, Rei Kanno, et al.
Pediatric Diabetes|July 1, 2017
NEUROD1-deficient diabetes (MODY6): Identification of the first cases in Japanese and the clinical featuresYukio Horikawa, Mayumi Enya, Hiroyo Mabe, et al.
Diabetes Care|March 1, 2003
RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjectsKunihiro Nakajima, Yasushi Tanaka, Takashi Nomiyama, et al.
Journal of Diabetes Investigation|January 8, 2026
Efficacy of probiotics (Bifidobacterium bifidum G9-1) in patients with type 2 diabetes mellitus and chronic kidney disease complicated by constipation: An exploratory, multicenter, open-label, single-arm study (BIRDIE study)Fuki Ikeda, Junko Sato, Hidenori Yoshii, et al.
Endocrine Journal|November 11, 2008
Aldose reductase inhibitor, epalrestat, reduces lipid hydroperoxides in type 2 diabetesChie Ohmura, Hirotaka Watada, Kosuke Azuma, et al.
Endocrine Journal|June 10, 2009
Dramatic improvement of blood glucose control after pioglitazone treatment in poorly controlled over-weight diabetic patients with myotonic dystrophyHiroko Abe, Tomoya Mita, Kyoko Kudo, et al.
American Journal of Hypertension|November 18, 2011
Masked hypertension, endothelial dysfunction, and arterial stiffness in type 2 diabetes mellitus: a pilot studyKageumi Takeno, Tomoya Mita, Shiho Nakayama, et al.
The Journal of International Medical Research|December 10, 2015
Effect of treatment guidance using a retrospective continuous glucose monitoring system on glycaemic control in outpatients with type 2 diabetes mellitus: A randomized controlled trialJunko Sato, Akio Kanazawa, Fuki Ikeda, et al.
Journal of Diabetes Investigation|February 4, 2026
Effects of switching from MiniMed™ 770G to 780G on continuous glucose monitoring metrics and DTR-QOL scores: An observational study of Japanese people with type 1 diabetes mellitusEri Takagi, Junko Sato, Tatsuhiro Ayame, et al.
Pediatric Diabetes|October 23, 2020
Left atrial dysfunction and stiffness in pediatric and adult patients with Type 1 diabetes mellitus assessed with speckle tracking echocardiographyMayumi Ifuku, Ken Takahashi, Yu Hosono, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|April 3, 2003
p38 MAPK is involved in activin A- and hepatocyte growth factor-mediated expression of pro-endocrine gene neurogenin 3 in AR42J-B13 cellsTakeshi Ogihara, Hirotaka Watada, Rei Kanno, et al.
Pediatric Diabetes|July 1, 2017
NEUROD1-deficient diabetes (MODY6): Identification of the first cases in Japanese and the clinical featuresYukio Horikawa, Mayumi Enya, Hiroyo Mabe, et al.
Diabetes Care|March 1, 2003
RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjectsKunihiro Nakajima, Yasushi Tanaka, Takashi Nomiyama, et al.
Journal of Diabetes Investigation|January 8, 2026
Efficacy of probiotics (Bifidobacterium bifidum G9-1) in patients with type 2 diabetes mellitus and chronic kidney disease complicated by constipation: An exploratory, multicenter, open-label, single-arm study (BIRDIE study)Fuki Ikeda, Junko Sato, Hidenori Yoshii, et al.
Endocrine Journal|November 11, 2008
Aldose reductase inhibitor, epalrestat, reduces lipid hydroperoxides in type 2 diabetesChie Ohmura, Hirotaka Watada, Kosuke Azuma, et al.
Endocrine Journal|June 10, 2009
Dramatic improvement of blood glucose control after pioglitazone treatment in poorly controlled over-weight diabetic patients with myotonic dystrophyHiroko Abe, Tomoya Mita, Kyoko Kudo, et al.
American Journal of Hypertension|November 18, 2011
Masked hypertension, endothelial dysfunction, and arterial stiffness in type 2 diabetes mellitus: a pilot studyKageumi Takeno, Tomoya Mita, Shiho Nakayama, et al.
The Journal of International Medical Research|December 10, 2015
Effect of treatment guidance using a retrospective continuous glucose monitoring system on glycaemic control in outpatients with type 2 diabetes mellitus: A randomized controlled trialJunko Sato, Akio Kanazawa, Fuki Ikeda, et al.
Journal of Diabetes Investigation|February 4, 2026
Effects of switching from MiniMed™ 770G to 780G on continuous glucose monitoring metrics and DTR-QOL scores: An observational study of Japanese people with type 1 diabetes mellitusEri Takagi, Junko Sato, Tatsuhiro Ayame, et al.
Pediatric Diabetes|October 23, 2020
Left atrial dysfunction and stiffness in pediatric and adult patients with Type 1 diabetes mellitus assessed with speckle tracking echocardiographyMayumi Ifuku, Ken Takahashi, Yu Hosono, et al.
Pageof 4